Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Quinolones Market Heading Into 2029?

There has been consistent expansion in the size of the quinolones market in the past few years. It is expected to escalate from $50.05 billion in 2024 to $51.89 billion in 2025, recording a compound annual growth rate (CAGR) of 3.7%. Factors contributing to the growth during the historic period include the rising demand for antibiotics, regulatory approvals, advancements in research and development, competitive conditions, and patent expirations.

In the coming years, the quinolones market is forecasted to experience robust expansion. The market is projected to reach ” $63.17 billion by 2029, registering a compound annual growth rate (CAGR) of 5.0%. Various factors such as the emergence of new diseases, modifications in regulations, evolution in global health policies, increase in antibiotic resistance, and strategies for market enlargement contribute to this growth. The forecast period will also notice trends like development of new products and alterations in the regulatory framework.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Which Factors Are Pushing The Quinolones Market Forward?

The quinolones market is experiencing substantial growth due to the increasing prevalence of infectious diseases. These diseases, caused by different types of microbes like bacteria, parasites, fungi, and viruses, are often treated using quinolones. Conditions such as urinary tract infections and tuberculosis, that are caused by bacterial infections, are notable examples. The World Health Organization published the Global Tuberculosis Report in November 2023, indicating that in 2022, there were 7.5 million newly diagnosed TB cases, a marked increase from 6.4 million in 2021. This rise in infectious diseases incidence is therefore driving the quinolones market.

Which Segment Held The Largest Share In The Quinolones Market In 2025?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

How Are Key Trends Driving Expansion In The Quinolones Industry?

The growing trend of product innovation has become increasingly noticeable in the quinolones market. The primary firms in the quinolones market are prioritizing the creation of imaginative products in order to preserve their status within the market. For example, Viatris’ South Korean operation, a pharmaceutical company based in the US, introduced Dovprela, a novel treatment for drug-resistant tuberculosis in January 2023. Dovprela, a combination of three drugs – bedaquiline, pretomanid, and linezolid (BPaL), is being employed to treat adult patients suffering from extensively drug-resistant TB and those who show resistance or non-responsiveness to multidrug-resistant TB. The effective anti-tuberculosis properties of Dovprela shorten the required treatment duration from 18-20 months to just 5-6 months.

Which Organizations Are Driving Progress In The Quinolones Industry?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Quinolones Industry?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model